February 11, 2015
Spellman DS et al. Prot Clin Appl 2015;9:715-731.
Development and Evaluation of a Multiplexed Mass Spectrometry-Based Assay for Measuring Candidate Peptide Biomarkers in Alzheimer’s Disease Neuroimaging Initiative (ADNI) CSF
You might also be interested by
News
CellCarta Joins Olink™ Certified Service Provider Network in China
February 13, 2025
Proteomics/Mass Spectrometry
More infoBrochures & Infographics
High Performance Technologies for Cytokine Measurement
July 29, 2024
Immune Monitoring
More info